Skip to main content
Have a personal or library account? Click to login
Effect of amygdalin on MCF-7, MDA-MB-231 and T-47D breast cancer cells in the in vitro study Cover

Effect of amygdalin on MCF-7, MDA-MB-231 and T-47D breast cancer cells in the in vitro study

Postępy Higieny i Medycyny Doświadczalnej
Volume 76 (2022): Issue 1 (January 2022)
By: ,  ,   and    
Open Access
|Apr 2022
Authors

Authors

Aleksandra Zielińska

azielinska@sum.edu.pl

Department of Medical Genetics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland

Justyna Płonka-Czerw

Department of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland

Agnieszka Nowak

Chair and Department of Chemistry, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland

Dariusz Kuśmierz

Department of Cell Biology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland
DOI: https://doi.org/10.2478/ahem-2022-0013 | Journal eISSN: 1732-2693
Journal RSS Feed
Language: English
Page range: 132 - 142
Submitted on: Mar 30, 2021
Accepted on: Jan 12, 2022
Published on: Apr 25, 2022
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
breast cancer,
amygdalin,
cell culture,
T-47D,
MDA-MB-231,
MCF-7,
HFF-1,
BAX,
BCL-2,
caspase 3
Related subjects:
Life sciences,
Molecular biology,
Microbiology and virology,
Medicine,
Basic medical science,
Immunology

© 2022 Aleksandra Zielińska, Justyna Płonka-Czerw, Agnieszka Nowak, Dariusz Kuśmierz, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 76 (2022): Issue 1 (January 2022)
Previous article
Next article